Lower plasma adipsin concentrations are described in animals and patients with type 2 diabetes mellitus, since its presence is important for improving hyperglycemia by preserving β-cell survival (Tafere et al., 2020). This evidence concerns the gene CFD and type 2 diabetes mellitus.